Suchergebnisse - "Effern, Maike"
-
1
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
ISSN: 2159-8290, 2159-8290Veröffentlicht: United States 01.12.2019Veröffentlicht in Cancer discovery (01.12.2019)“… We explored the mechanism of action of CD39 antibodies that inhibit ectoenzyme CD39 conversion of extracellular ATP (eATP) to AMP and thus potentially augment …”
Weitere Angaben
Journal Article -
2
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma
ISSN: 1549-5477, 1549-5477Veröffentlicht: United States 01.01.2017Veröffentlicht in Genes & development (01.01.2017)“… The intratumor microenvironment generates phenotypically distinct but interconvertible malignant cell subpopulations that fuel metastatic spread and …”
Weitere Angaben
Journal Article -
3
Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression
ISSN: 2162-402X, 2162-4011, 2162-402XVeröffentlicht: United States Taylor & Francis 03.06.2017Veröffentlicht in Oncoimmunology (03.06.2017)“… Immune checkpoint inhibitors have significantly improved the treatment of several cancers. T-cell infiltration and the number of neoantigens caused by …”
Volltext
Journal Article -
4
From Tpex to Tex: a journey through CD8+ T cell responses in cancer immunotherapy
ISSN: 2059-3635, 2095-9907, 2059-3635Veröffentlicht: London Nature Publishing Group UK 04.09.2023Veröffentlicht in Signal transduction and targeted therapy (04.09.2023)Volltext
Journal Article -
5
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma
ISSN: 2051-1426, 2051-1426Veröffentlicht: England BMJ Publishing Group Ltd 07.04.2023Veröffentlicht in Journal for immunotherapy of cancer (07.04.2023)“… BackgroundImmune responses against tumors are subject to negative feedback regulation. Immune checkpoint inhibitors (ICIs) blocking Programmed cell death …”
Volltext
Journal Article -
6
CRISPitope: A generic platform to model target antigens for adoptive T cell transfer therapy in mouse tumor models
ISSN: 2666-1667, 2666-1667Veröffentlicht: United States Elsevier Inc 18.03.2022Veröffentlicht in STAR protocols (18.03.2022)“… This protocol details the procedure for CRISPR-assisted insertion of epitopes (CRISPitope), a flexible approach for generating tumor cells expressing model …”
Volltext
Journal Article -
7
Not Sweet: Glucocorticoids from Intratumoral Myeloid Cells Disable T Cells
ISSN: 1097-4180, 1097-4180Veröffentlicht: United States 15.09.2020Veröffentlicht in Immunity (Cambridge, Mass.) (15.09.2020)“… In this issue, Acharya et al. demonstrate that glucocorticoids produced by macrophages and monocytes in the tumor microenvironment induce a dysfunctional CD8 …”
Weitere Angaben
Journal Article -
8
Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin
ISSN: 0028-0836, 1476-4687, 1476-4687Veröffentlicht: London Nature Publishing Group UK 17.01.2019Veröffentlicht in Nature (London) (17.01.2019)“… The immune system can suppress tumour development both by eliminating malignant cells and by preventing the outgrowth and spread of cancer cells that resist …”
Volltext
Journal Article -
9
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8 + T Cells
ISSN: 1097-4180, 1097-4180Veröffentlicht: United States 13.10.2020Veröffentlicht in Immunity (Cambridge, Mass.) (13.10.2020)“… The activating receptor CD226 is expressed on lymphocytes, monocytes, and platelets and promotes anti-tumor immunity in pre-clinical models. Here, we examined …”
Weitere Angaben
Journal Article -
10
The experimental power of FR900359 to study Gq-regulated biological processes
ISSN: 2041-1723, 2041-1723Veröffentlicht: London Nature Publishing Group UK 14.12.2015Veröffentlicht in Nature communications (14.12.2015)“… Despite the discovery of heterotrimeric αβγ G proteins ∼25 years ago, their selective perturbation by cell-permeable inhibitors remains a fundamental …”
Volltext
Journal Article -
11
T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels
ISSN: 1097-4180, 1097-4180Veröffentlicht: United States 12.11.2024Veröffentlicht in Immunity (Cambridge, Mass.) (12.11.2024)“… To improve immunotherapy for brain tumors, it is important to determine the principal intracranial site of T cell recruitment from the bloodstream and their …”
Weitere Angaben
Journal Article -
12
RNase T2 restricts TLR13-mediated autoinflammation in vivo
ISSN: 1540-9538, 1540-9538Veröffentlicht: United States 03.03.2025Veröffentlicht in The Journal of experimental medicine (03.03.2025)“… RNA-sensing TLRs are strategically positioned in the endolysosome to detect incoming nonself RNA. RNase T2 plays a critical role in processing long, structured …”
Weitere Angaben
Journal Article -
13
Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in Melanoma
ISSN: 1097-4180, 1097-4180Veröffentlicht: United States 15.09.2020Veröffentlicht in Immunity (Cambridge, Mass.) (15.09.2020)“… Tumor immune escape limits durable responses to T cell therapy. Here, we examined how regulation and function of gene products that provide the target epitopes …”
Weitere Angaben
Journal Article -
14
Author Correction: Tissue-resident memory CD8.sup.+ T cells promote melanoma-immune equilibrium in skin
ISSN: 0028-0836Veröffentlicht: Nature Publishing Group 01.02.2019Veröffentlicht in Nature (London) (01.02.2019)“… Panel j was inadvertently labelled as panel k in the caption to Fig. 4. Similarly, 'Fig. 4k' should have been 'Fig. 4j' in the sentence beginning …”
Volltext
Journal Article -
15
Tissue-resident memory CD8.sup.+ T cells promote melanoma-immune equilibrium in skin
ISSN: 0028-0836Veröffentlicht: Nature Publishing Group 01.01.2019Veröffentlicht in Nature (London) (01.01.2019)“… The immune system can suppress tumour development both by eliminating malignant cells and by preventing the outgrowth and spread of cancer cells that resist …”
Volltext
Journal Article -
16
CD4 + T cell immunity against cutaneous melanoma encompasses multifaceted MHC II-dependent responses
ISSN: 2470-9468, 2470-9468Veröffentlicht: United States 19.01.2024Veröffentlicht in Science immunology (19.01.2024)“… Whereas CD4 T cells conventionally mediate antitumor immunity by providing help to CD8 T cells, recent clinical studies have implied an important role for …”
Weitere Angaben
Journal Article -
17
Meeting Report: 47th Annual Meeting of the “Arbeitsgemeinschaft Dermatologische Forschung”
ISSN: 0906-6705, 1600-0625, 1600-0625Veröffentlicht: Denmark Wiley Subscription Services, Inc 01.10.2022Veröffentlicht in Experimental dermatology (01.10.2022)Volltext
Journal Article -
18
Altered Notch Signaling in Dowling-Degos Disease: Additional Mutations in POGLUT1 and Further Insights into Disease Pathogenesis
ISSN: 1523-1747, 1523-1747Veröffentlicht: United States 01.04.2019Veröffentlicht in Journal of investigative dermatology (01.04.2019)Weitere Angaben
Journal Article -
19
Tissue-resident memory CD8^sup +^ T cells promote melanoma–immune equilibrium in skin
ISSN: 0028-0836, 1476-4687Veröffentlicht: London Nature Publishing Group 17.01.2019Veröffentlicht in Nature (London) (17.01.2019)“… The immune system can suppress tumour development both by eliminating malignant cells and by preventing the outgrowth and spread of cancer cells that resist …”
Volltext
Journal Article -
20
Author Correction: Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin
ISSN: 0028-0836, 1476-4687, 1476-4687Veröffentlicht: London Nature Publishing Group UK 01.02.2019Veröffentlicht in Nature (London) (01.02.2019)“… Panel j was inadvertently labelled as panel k in the caption to Fig. 4. Similarly, ‘Fig. 4k’ should have been ‘Fig. 4j’ in the sentence beginning …”
Volltext
Journal Article